Beauty Farm Medical and Health Industry Inc.: management transactions · Hong Kong · HKEX HKEX:beauty-farm-medical-and-health-industry-inc HK HK · HKEX Mcap 4.9Bn€ Healthcare
Browse the full insider trade history of Beauty Farm Medical and Health Industry Inc., a publicly traded company based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Healthcare sector, Beauty Farm Medical and Health Industry Inc. has published 12 insider filings. Market capitalisation: €4.9bn. The latest transaction was disclosed on 8 April 2026 — Purchase. Among the most active insiders: Li Fangyu. All data is openly available.
€327,032
12 ops.
Buy Volume
Financial data FY ended December 2025 · cache
Analyst consensus
5 analysts · 29.34 € Target 35.03 €(+80%) 39.11 €
Income statement
Revenue 3.00 Bn€
Gross profit 1.47 Bn€ 49% margin
Net income 317.6 M€ 10.6% margin
Valuation
PER (trailing) 12.3x
PER (forward) 8.0x
P/Book 3.9x
Beta 1.34
Balance sheet & cash
Market cap 4.86 Bn€
Total debt 1.29 Bn€
Free Cash Flow 932.0 M€
Debt / Equity 121%
Profitability & ownership
ROE 33.3%
ROA 6.1%
% insiders 59.7%
% institutions 4.8%
Last declaration on 8 April 2026
Declarations 12 total
Executives ● Purchase8 HKEX
€26,149 12,000 shares @ €2.1791 0.0005% mcap 24.0% of flow
HKEX:DA20260402E00687 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase7 HKEX
€12,050 5,500 shares @ €2.1909 0.0002% mcap 11.1% of flow
HKEX:DA20260403E00269 · 1 Apr 2026
Ideal exit: 27 Dec 2026 (T+270) Executives ● Purchase7 HKEX
€12,050 5,500 shares @ €2.1909 0.0002% mcap 11.1% of flow
HKEX:DA20260403E00267 · 1 Apr 2026
Ideal exit: 27 Dec 2026 (T+270) Executives ● Purchase8 HKEX
€26,149 12,000 shares @ €2.1791 0.0005% mcap 24.0% of flow
HKEX:DA20260402E00690 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€42,086 19,500 shares @ €2.1582 0.0009% mcap 38.6% of flow
HKEX:DA20260403E00266 · 2 Apr 2026
Ideal exit: 28 Dec 2026 (T+270) Executives ● Purchase7 HKEX
€12,050 5,500 shares @ €2.1909 0.0002% mcap 11.1% of flow
HKEX:DA20260403E00265 · 1 Apr 2026
Ideal exit: 27 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€42,086 19,500 shares @ €2.1582 0.0009% mcap 38.6% of flow
HKEX:DA20260403E00270 · 2 Apr 2026
Ideal exit: 28 Dec 2026 (T+270) Executives ● Purchase8 HKEX
€26,149 12,000 shares @ €2.1791 0.0005% mcap 24.0% of flow
HKEX:DA20260402E00691 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€42,086 19,500 shares @ €2.1582 0.0009% mcap 38.6% of flow
HKEX:DA20260403E00268 · 2 Apr 2026
Ideal exit: 28 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€28,726 13,500 shares @ €2.1278 0.0006% mcap 26.4% of flow
HKEX:DA20260402E00285 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€28,726 13,500 shares @ €2.1278 0.0006% mcap 26.4% of flow
HKEX:DA20260402E00308 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€28,726 13,500 shares @ €2.1278 0.0006% mcap 26.4% of flow
HKEX:DA20260402E00300 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270)